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Background
Infection with hepatitis C virus (HCV) is a major public
health problem worldwide due to asymptomatic evolu-
tion to cirrhosis and liver cancer. In patients with
chronic liver disease, the precise definition of the stage
of liver fibrosis is important for prognosis and monitor-
ing of the evolution of liver disease and the outcome of
antiviral therapy in chronic HCV infection. Activation of
hepatic stellate cells (HSCs) and transformation into
myofibroblasts is the central event in liver fibrosis.
Methods
The aim of this study was to perform clinical and histolo-
gical correlations in patients with chronic HCV infection.
The study was based on clinical and laboratory data,
including liver histology, recorded in a group of patients
admitted to the Emergency County Hospital Oradea,
Department of Clinical Gastroenterology.
Results
The study included 137 patients aged 19 to 69 years. The
balance in terms of gender representation was slightly
inclined towards the female gender with a percentage of
58.76%.
Approximately two thirds of patients (66.06%) had ages
between 36 and 55, slightly higher for the age group 46-55
years (33.58% versus 32.48%). We examined between
4 and 24 vein spaces, with an average of 7.8 portal spaces
and a standard derivation of 3.82, mostly from 4 to
11 areas examined. Most patients were at their first liver
biopsy (88.32%), 9.49% at the second biopsy, and 5 patients
(1.82%) had previously undergone 3 to 4 punctures. The
following fibrosis stages were recorded: F0 6.2%, F1:
40.51%, F2 36.5 %, and F3 16.79%.
Most (24.45%) had portal fibrosis without septa and
mild inflammatory activity, the next had portal fibrosis
with rare septa of fibrosis and mild activity (10.22%) and
6.2% with severe activity.
The age group over 66 years did not present cases of
chronic hepatitis without fibrosis and the age group up to
25 years did not present cases of chronic hepatitis with
fibrosis F3. For the age group 46-55 years predominate F3
(6.2%) and F1 (14.23%), F2 36-45 (12.77%).
Conclusion
For the clinician, the fibrosis progression is the most faith-
ful parameter of the evolution of liver disease.
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